Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Clobetasol propionate 0.05% ointment is more effective than tacrolimus 0.1% ointment for treating alopecia areata.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

Baricitinib is effective and safe for treating severe alopecia areata.

Tofacitinib may help treat severe hair loss, but more research is needed.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Shaoyao Gancao decoction may treat alopecia areata by affecting the PI3K/AKT signaling pathway.

Monthly PRP therapy is more effective than daily minoxidil for alopecia areata.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Elevated granulysin levels may indicate disease activity in vitiligo and alopecia areata.

Computer vision techniques can help detect and assess skin conditions like vitiligo, alopecia areata, and dermatitis.

Baricitinib is effective and safe for long-term treatment of severe alopecia areata.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Measuring bald patch size can help grade hair loss severity, with photograph-based evaluation being more reliable.

Alopecia areata involves specific immune cells, offering potential treatment targets.

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Oral betamethasone mini-pulses effectively treat moderate to severe alopecia areata with manageable side effects.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

Females are more affected by immune-related skin diseases, needing targeted health interventions.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Distinct miRNA signatures could help diagnose and treat severe Alopecia Areata.

Oxidative stress may play a role in alopecia areata, but depression and suicide risk are similar to healthy peers.